1. AB0393 Efficacy and Safety of Etanercept (ETN) in Patients with Moderately Active Rheumatoid Arthritis (RA) despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy. (10th June 2014) Authors: Hobbs, K.; Chung, J.; Bitman, B.; Wang, B.; Nussbaum, J.; Collier, D.H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0263 Biologic Therapy, Time to Low Disease Activity, and Effect of Mono Vs. Background Oral Dmard Therapy Among Psoriatic Arthritis Patients in a US Registry. (23rd January 2014) Authors: Mease, P.; Collier, D.; Saunders, K.; Grant, S.; Bitman, B.; Chaudhari, M.; Greenberg, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0122 Etanercept Treatment Does Not Adversely Affect Traditional Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Deodhar, A.; Bitman, B.; Yang, Y.; Collier, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0174 Comparison of Switching to Reduced Dose VS Continuation of Standard Dose Etanercept for Rheumatoid Arthritis Patients in the Corrona Registry. (10th June 2014) Authors: Greenberg, J.D.; Shan, Y.; Reed, G.W.; Bitman, B.; Collier, D. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗